UM  > Faculty of Health Sciences
Targeting RNA helicase DHX33 blocks Ras-driven lung tumorigenesis in vivo
Wang,Xingshun1,2; Feng,Weimin1; Peng,Cheng1,2; Chen,Shiyun1; Ji,Hongbin3,4,5,6; Zhong,Hanbing1; Ge,Wei2; Zhang,Yandong1,7
2020-10-01
Source PublicationCancer Science
ISSN1347-9032
Volume111Issue:10Pages:3564-3575
AbstractRas has been found to be mutated in 30% of non-small cell lung cancers, and its mutation has been regarded as a causal factor underlying tumorigenesis. However, no successful medicine has been developed so far to inhibit Ras for lung cancer treatment. We have previously identified DHX33 as a Ras downstream effector, promoting cell cycle progression and cell growth. In this study, with the K-Ras (G12D);DHX33 (lox/lox) mouse model, we discovered that genetic ablation of DHX33 inhibited tumor development. We further found that ablation of DHX33 altered the expression of nearly 2000 genes which are critical in cancer development such as cell cycle, apoptosis, glycolysis, Wnt signaling, and cell migration. Our study for the first time demonstrates the pivotal role of the DHX33 in Ras-driven lung cancer development in vivo and highlights that pharmacological targeting DHX33 can be a feasible option in treating Ras-mutant lung cancers.
KeywordDHX33 lung cancer oncogene Ras RNA helicase
DOI10.1111/cas.14601
URLView the original
Language英语
Fulltext Access
Citation statistics
Cited Times [WOS]:1   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionFaculty of Health Sciences
Corresponding AuthorZhang,Yandong
Affiliation1.Department of Biology,Southern University of Science and Technology,Shenzhen,China
2.Faculty of Health Sciences,University of Macau,Macao
3.State Key Laboratory of Cell Biology,Shanghai,China
4.CAS Center for Excellence in Molecular Cell Science,Shanghai,China
5.Innovation Center for Cell Signaling Network,Institute of Biochemistry and Cell Biology,Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences,Shanghai,China
6.School of Life Science and Technology,Shanghai Tech University,Shanghai,China
7.KeYe Life Technologies Co.,Ltd,Shenzhen,China
First Author AffilicationFaculty of Health Sciences
Recommended Citation
GB/T 7714
Wang,Xingshun,Feng,Weimin,Peng,Cheng,et al. Targeting RNA helicase DHX33 blocks Ras-driven lung tumorigenesis in vivo[J]. Cancer Science,2020,111(10):3564-3575.
APA Wang,Xingshun,Feng,Weimin,Peng,Cheng,Chen,Shiyun,Ji,Hongbin,Zhong,Hanbing,Ge,Wei,&Zhang,Yandong.(2020).Targeting RNA helicase DHX33 blocks Ras-driven lung tumorigenesis in vivo.Cancer Science,111(10),3564-3575.
MLA Wang,Xingshun,et al."Targeting RNA helicase DHX33 blocks Ras-driven lung tumorigenesis in vivo".Cancer Science 111.10(2020):3564-3575.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Wang,Xingshun]'s Articles
[Feng,Weimin]'s Articles
[Peng,Cheng]'s Articles
Baidu academic
Similar articles in Baidu academic
[Wang,Xingshun]'s Articles
[Feng,Weimin]'s Articles
[Peng,Cheng]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Wang,Xingshun]'s Articles
[Feng,Weimin]'s Articles
[Peng,Cheng]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.